KV1.3 channel inhibitor (Vascular Research Group)

N/A

Report date: 2025/03/20 16:07:40

Base Information

Drug NameKV1.3 channel inhibitor (Vascular Research Group)
Drug Alias NameKCNA3 channel inhibitor (Vascular Research Group)
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVascular Research Group Kft
China Registration ClassN/A

Develop Information

Active CompaniesVascular Research Group Kft
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A